MyFinsight
Home
Blog
About
Contact
Download
Download image
Financial royalty assets
$854,386K
(9.01%↑ Y/Y)
Cash and cash
equivalents
$618,696K
(-33.40%↓ Y/Y)
Other royalty income
receivable
$29,316K
(8.76%↑ Y/Y)
Available for sale debt
securities
$18,800K
(-67.70%↓ Y/Y)
Other current assets
$6,893K
(64.63%↑ Y/Y)
Financial royalty assets,
net
$16,208,482K
(7.15%↑ Y/Y)
Total current assets
$1,528,091K
(-15.21%↓ Y/Y)
Goodwill
$924,634K
Available for sale debt
securities
$419,000K
(-39.58%↓ Y/Y)
Equity method
investments
$289,968K
(-23.58%↓ Y/Y)
Equity securities
$171,312K
(-8.37%↓ Y/Y)
Other assets
$79,293K
(136.46%↑ Y/Y)
Total assets
$19,620,780K
(7.67%↑ Y/Y)
Total liabilities and
shareholders equity
$19,620,780K
(7.67%↑ Y/Y)
Total liabilities
$9,905,841K
(25.70%↑ Y/Y)
Total shareholders
equity
$9,714,939K
(-6.07%↓ Y/Y)
Treasury interests
$2,612K
(-1.88%↓ Y/Y)
Long-term debt
$8,570,917K
(29.57%↑ Y/Y)
Total current
liabilities
$636,211K
(-49.25%↓ Y/Y)
Accrued compensation
liabilities
$577,870K
Other liabilities
$120,843K
(900.36%↑ Y/Y)
Additional paid-in capital
$4,123,088K
(0.48%↑ Y/Y)
Non-controlling interests
$3,238,039K
(-4.65%↓ Y/Y)
Retained earnings
$2,356,318K
(-17.20%↓ Y/Y)
Common stock-Class
RRedeemable Stock
$63K
(0.00%↑ Y/Y)
Common stock-Common
Class A
$43K
(-4.44%↓ Y/Y)
Current portion of
long-term debt
$380,000K
(138.08%↑ Y/Y)
Interest payable
$110,818K
(13.01%↑ Y/Y)
Distributions payable to
legacy...
$72,825K
(-3.94%↓ Y/Y)
Other current
liabilities
$53,164K
(-22.50%↓ Y/Y)
Accounts payable and
accrued expenses
$19,404K
(45.13%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)